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An orthogonal reaction is a concept developed in organic chemistry to achieve highly specific 
conjugation, allowing exploration of biological interactions in complex systems.[1] The 
success of such reactions relies on specific chemical bond formation. Similar concepts 
however have not been applied at the bio-nano interface for adsorption. It is often conceived 
that two adsorbates typically compete for surface binding site. For many applications it is 
highly desirable to adsorb multiple molecules on the same surface with little intermolecular 
competition, where co-delivery, controlled release, multiplexed sensing and directed assembly 
might be achieved. While this goal might be realized by orthogonal covalent conjugation to a 
surface or by preparing janus particles,[2] physisorption is more desirable in many cases since 
it is reversible and cost-effective. 
Physisorption relies on weak intermolecular forces including electrostatic interaction, 
van der Waals force, aromatic stacking, hydrogen bonding, hydration, and hydrophobic 
force.[3] We reason that it might be possible to achieve orthogonal adsorption based on forces 
that are of non-competing origin and are spatially non-co-localizing on the surface. An 
essential requirement is thus nanoscale heterogeneity on the surface. While many surfaces are 
quite uniform at nanoscale and can interact with only one type of molecule, a recently 
developed material, graphene oxide (GO), might be suitable for this purpose. Graphene is 
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single-layered graphite with a very large specific surface area.[4] Since pristine graphene is 
extremely hydrophobic, GO with surface hydroxyl, carboxyl, and epoxy groups are often 
prepared to facilitate dispersion in water and to interface with biological systems.[5] GO is 
negatively charged with sp2 carbons, enabling effectively adsorption of positively charged 
aromatic molecules such as doxorubicin. For this reason, GO has been commonly used as a 
delivery vehicle for such drugs.[6-12] It is known that most of the carboxyl groups are 
distributed at the edge of GO while the interior regions are more hydrophobic.[13] This 
nanoscale spatial separation of the surface property may allow the engineering of different 
adsorption interactions. 
To demonstrate orthogonal adsorption, we need to identify molecules that might 
interact with GO via non-electrostatic and non-hydrophobic/aromatic interactions. We reason 
that zwitterionic lipids such as dioleoyl-sn-glycero-3-phosphocholine (DOPC) might be 
appropriate for this purpose. A few recent reports show that graphene, GO, carbon nanotubes 
and other nanomaterials could adsorb liposomes.[14] When dispersed in water, DOPC 
liposomes expose hydrophilic head groups, eliminating hydrophobic interactions. 
Electrostatic force is also unlikely to play an important role since DOPC is overall charge 
neutral. As a result DOPC liposomes may be adsorbed on sites different from doxorubicin to 
avoid competition. Since liposomes can contain many different types of cargos in their 
internal aqueous compartment, a general multiplexed delivery platform might be achieved. 
Herein we communicate that GO adsorption of zwitterionic DOPC liposomes is orthogonal to 
the GO adsorption of doxorubicin. In addition, free DOPC liposomes are not internalized by 
HeLa cells while the DOPC/GO complex has high colloidal stability and readily enters the 
cells. In this regard, GO also facilitates cellular uptake of zwitterionic liposomes. 
Our DOPC liposomes were prepared using the standard extrusion method 
(hydrodynamic diameter = 123 nm by dynamic light scattering (DLS), Figure 1A, solid black 
trace). All the previous work used large GO sheets to interface with liposomes.[14] To 
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encourage cellular uptake, we herein prepared nano-GO of ~100 nm (Figure 1A, solid gray 
trace). Transmission electron microscopy confirmed the down size of GO sheets from 
micrometer to below 100 nm (Figure S1, Supporting Information). Adsorption of DOPC 
liposome to GO was achieved by simply mixing them and this reaction was monitored by 
DLS (Figure 1B). Nano-GO was gradually titrated into the liposome solution and the size of 
the complex increased gradually to ~180 nm at a weight ratio of DOPC:GO=1:4. After that, 
the average size decreased, probably due to the excess amount of GO dominating the light 
scattering signal. It is quite interesting to note that the system did not aggregate for all tested 
ratios, while aggregation is commonly expected for such nanoparticle systems with attractive 
forces. For example, if DOPC is added to large GO sheets, very large aggregates were formed 
since each GO sheet adsorbs multiple liposomes and each liposome can also bind to multiple 
GO sheets (Figure S2). For further comparison, we mixed nano-GO with cationic DOTAP 
liposomes of similar sizes, where the size of the complex increased drastically (Figure 1A, 
dashed black trace and Figure 1B, gray triangles), indicating extensive aggregation of nano-
GO mediated by DOTAP. Therefore, the adsorption strength of DOPC appears to be 
appropriate since it offers stable colloids at any given ratio. For the subsequent studies, we 
only used DOPC since it has good colloidal stability and has few toxic concerns. The Cryo-
TEM micrograph in Figure 1C shows the morphology of this complex, where the spherical 
shape of the liposomes is maintained. The kinetics of liposome adsorption was monitored 
using a rhodamine (Rh)-labeled DOPC liposome, where immediate fluorescence quenching 
was observed upon mixing the liposome with GO, suggesting fast binding kinetics (Figure 
S3). The -potential of our DOPC is -1.7 mV and GO is -24 mV. The complex showed a -
potential of -32 mV, suggesting that a large fraction of the complex is covered by GO. The 
DOPC adsorption capacity was determined using centrifugation; each mg of nano-GO 
adsorbed 3.4 mg DOPC (Figure S4). 
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Figure 1. (A) DLS spectra of liposomes, nano-GO and their complexes. (B) The average size 
of the DOPC or DOTAP/nano-GO complexes at different ratios. (C) Cryo-TEM micrographs 
of DOPC/nano-GO complexes. The one on the left has a large piece of GO and the one on the 
right has a few small GO pieces. (D) Loading capacity of nano-GO and its DOPC complex for 
doxorubicin. Displacement of calcein loaded DOPC by doxorubicin measured after 
centrifugation. The supernatant (E) and the pellet (F) fluorescence before and after adding 
Triton X-100 were compared. (G) Schematics of adsorption of DOPC liposomes on the 
hydrophilic regions of GO and the hydrophobic region can adsorb doxorubicin (denoted by 
the black poly-rings). 
Since an important goal of this work is to test orthogonal adsorption, we next 
measured the adsorption capacity doxorubicin. Interestingly, the capacity was even slightly 
greater when nano-GO was first mixed with DOPC (Figure 1D), suggesting that the liposome 
did not compete with doxorubicin. Our control experiment shows that DOPC liposome does 
not adsorb doxorubicin (Figure S6) and this increased adsorption is attributed to that the 
dispersion of nano-GO was improved by liposome adsorption. For example, the doxorubicin 
loading capacity on micrometer-sized GO is less than half of that on nano-GO of the same 
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w/w concentration (Figure S7). Doxorubicin causes stacking and aggregation of large GO 
sheets, masking a fraction of its surface area. While doxorubicin induced aggregation is 
significantly reduced with nano-GO, liposomes can further minimize it. 
To further confirm orthogonal adsorption, we employed calcein loaded DOPC as a 
probe. We did not use Rh-DOPC since the emissions of Rh and doxorubicin overlap. We 
mixed calcein-loaded DOPC with nano-GO and then added a saturating amount of 
doxorubicin. The sample was centrifuged to precipitate the GO/liposome complex while the 
supernatant contained the free liposome. The fluorescence intensity of both the supernatant 
and the precipitant before and after adding Triton X-100 was compared (Figure 1E, F). Since 
the calcein concentration inside the liposomes was very high (~100 mM), its fluorescence was 
self-quenched. Triton X-100 ruptures the liposome to release calcein, where Triton-induced 
fluorescence measures the amount of intact liposomes. For the supernatant sample, Triton 
barely changed the calcein emission at 515 nm, suggesting that no liposome was released into 
the supernatant. The other two peaks at longer wavelengths are from doxorubicin, indicating 
that doxorubicin was added in excess. On the other hand, the pellet showed significant 
increase in the calcein fluorescence, confirming that intact liposomes were adsorbed by nano-
GO. Therefore, doxorubicin did not displace the liposome. In other words, doxorubicin and 
DOPC have their respective binding sites and orthogonal adsorption was achieved. We further 
confirmed that adsorption of nano-GO to calcein loaded DOPC did not induce liposome 
leakage (Figure S8). Since DOPC and doxorubicin do not compete with each other, we 
propose that DOPC is adsorbed by the carboxyl and hydroxyl of the nano-GO sheets based on 
hydrogen bonding and hydration forces. Since the carboxyl groups are mostly on the edge of 
the GO sheets, adsorption of doxorubicin onto the more hydrophobic and aromatic regions are 
not affected.[15] The above samples were prepared by adsorbing the liposome first followed by 
adding doxorubicin. We also mixed nano-GO with doxorubicin followed by the addition of 
calcein-loaded DOPC (Figure S9). DOPC was also adsorbed without displacing doxorubicin, 
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further confirming the notion of orthogonal adsorption. A scheme of the adsorbed complex is 
presented in Figure 1G. 
This orthogonal adsorption system is ideal for multiplexed drug delivery since various 
cargos with different properties can be loaded on a single vehicle. To explore whether this 
nano-GO/liposome complex could be internalized by cells, we first tested its colloidal 
stability in cell culture conditions (Figure 2A), where the complex was stably dispersed in all 
the tested conditions. For comparison, micrometer-sized GO sheets were easily aggregated in 
saline or in culture medium (Figure 2B). To prevent aggregation, polyethylene glycol (PEG) 
was commonly covalently attached to GO.[6, 8] Herein, physisorbed zwitterionic liposomes 
appear to achieve a similar goal. Compared to PEG, DOPC requires no covalent bonding and 
can also contain drugs. To track the liposomes, we employed the Rh-labeled DOPC and 
varied the concentration of GO. Cellular uptake was first examined using epi-fluorescence 
microscopy (Figure 2C). The cell nuclei were stained blue. Almost no liposome uptake was 
observed for the free liposome, consistent with the notion that DOPC liposomes have little 
interaction with cells. Red fluorescence indicating liposome was observed when the weight of 
GO was twice of that of DOPC; very intense fluorescence was achieved at a 5:1 ratio. To 
confirm that the observed fluorescence is indeed due to cellular internalization instead of 
surface binding, laser scanning confocal fluorescence microscopy was used to image the cells 
(Figure S10). The confocal slices indicate that the red fluorescence is associated with the 
interior of the cell. 
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Figure 2. Colloidal stability test of DOPC/nano-GO complex (A) and micrometer-sized GO 
(B) in various solutions. (C) Epi-fluorescence micrographs of Rh-DOPC/nano-GO complex 
uptake as a function of the ratio (w/w) between these two. Confocal fluorescence micrographs 
of HeLa cells incubated with Rh-DOPC alone (D); with Rh-DOPC/nano-GO complex at 37 
C (E) for 1 hr, or at 37 C for 4 hr (F). The cytoskeleton actin in (D-F) was stained in green 
and the nucleus was stained in blue. 
Since the complex contains a liposome component, there might be a few possible 
mechanisms for cellular uptake, such as endocytosis or liposome fusion with the cell 
membrane. To test it, the cells were incubated at 4 C and no uptake was observed (Figure 
S11A), suggesting uptake is an energy-dependent process. Confocal microscopy also 
confirmed the lack of internalization of free Rh-DOPC (Figure 2D). With the same incubation 
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time, internalization was observed at 37 C (Figure 2E). After 4 hrs, very strong red 
fluorescence was observed, suggesting a high level of cellular uptake (Figure 2F). We next 
incubated the cells with Lysotracker Green to stain the acidic vesicles, where red fluorescence 
indicating liposome overlaps with the green lysosomes, suggesting endocytosis as the uptake 
mechanism (Figure S11B). 
In designing our experiment, we reasoned that nano-sized GO should be used for 
delivery to facilitate internalization. For comparison, we also employed micrometer sized GO 
to form complex with Rh-labeled DOPC. After incubating it with cells, no sign of red 
fluorescence indicative of DOPC liposome was observed (Figure S11C), suggesting that there 
was neither uptake nor cell surface binding. Therefore, the size of the delivery vehicle is also 
very important for cellular uptake. 
GO has been showed in many cases to be a useful material for drug delivery. In this 
work, we demonstrate orthogonal adsorption of DOPC and doxorubicin, where multiplexed 
delivery might be achieved. To test this, after adsorbing this calcein-loaded DOPC by GO, 
doxorubicin was added. The complex was incubated with cells (Figure 3A), where we 
observed both green fluorescence from calcein and red fluorescence from doxorubicin. Note 
in this case the liposome was not labeled with Rh. For comparison, we incubated the cells 
with calcein/DOPC and no green fluorescence was observed (Figure 3B), confirming that the 
green fluorescence in Figure 3A was due to nano-GO adsorption. 
   Submitted to  
 9 
 
Figure 3. (A) Confocal fluorescence micrographs of co-delivery of calcein and doxorubicin 
using the calcein-loaded DOPC and nano-GO. (B) Delivery of calcein/DOPC alone. Cell 
viability measured using MTT assay for free DOPC (C) and the nano-GO complex with or 
without doxorubicin (DOX) (D). For the blue and green dots in (D), doxorubicin is half of the 
nano-GO mass concentration. 
Finally, we studied the toxicity of the carriers using the MTT assay. There was almost 
no toxicity associated with DOPC liposome alone even at 20 g mL-1 (Figure 3C). The 
highest liposome concentration we used in this study was just 4 g mL-1. GO was toxic at a 
concentration higher than 5 g mL-1, where ~10% cells lost viability. The complex toxicity 
follows the GO toxicity, suggesting the DOPC did not hamper cellular uptake of the nano-GO 
sheets. With the GO concentration needed for delivery of liposome, the toxicity of the vehicle 
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is minimal. When loaded with doxorubicin, the vehicle was able to kill cancer cells 
effectively (blue dots), where the efficacy was slightly below that achieved with the free drug 
(green squares). This is commonly observed when doxorubicin is adsorbed onto GO-based 
drug carriers since the drug needs to desorb to be effective.[16] Using a drug carrier on the 
other hand allows potential targeted delivery while free drugs can also kill healthy cells. 
In summary, we have demonstrated that adsorption of DOPC and doxorubicin by 
nano-GO is orthogonal since they do not displace each other and the adsorption capacity is 
comparable in the presence or absence of the other molecule. This is attributed to the different 
intermolecular forces responsible for adsorbing each species. While this work is based on the 
surface heterogeneity of GO, the same design concept can be applied to engineer many other 
types of orthogonal adsorption. One way to achieve this is to decorate graphene with various 
nanoparticles, such AuNPs, mesoporous silica nanoparticles, Pd, quantum dots, magnetic 
nanoparticles, and oxides.[17] These complexes have already been used to enhance catalysis, 
battery energy storage, separation, imaging and for drug delivery. These attached 
nanoparticles may offer other types of intermolecular and surface forces, although they may 
also increase toxicity at the same time. Despite numerous reports on inorganic nanoparticles 
complexed with GO, this is the first report of using a soft nanoparticle for drug delivery. 
Beyond graphene related systems, many other types of nano-engineered materials might also 
be suitable substrates for orthogonal adsorption. For example, mesorporous silica 
nanoparticles can have different surface properties on the surface and in the pores.[18] There 
are also many types of hybrid nanorods and nanoparticles exposing different surface 
groups.[19] Finally, even the soft lipid membrane can be engineered to show phase separation, 
thus attracting different molecules at each phase.[20] In this work, we demonstrated DOPC and 
doxorubicin as a pair of orthogonal molecule. Other pairs might be designed based on the 
chemistry of nano-engineered materials. Beyond the concept of orthogonal adsorption, this 
liposome/nano-GO system also displays many interesting colloidal properties. For example, at 
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any given ratio, no large aggregates were formed and this system remained stable with sub-
200 nm size. This is not the case if larger GO sheets or cationic liposomes were used. By 
coating zwitterionic DOPC liposomes with nano-GO, cellular uptake of the whole system 
becomes very efficient. With this new delivery system, we realized the co-delivery of two 
molecules with opposite properties, where calcein is negatively charged and hydrophilic while 
doxorubicin is cationic and slightly hydrophobic. While there are numerous types of materials 
that can be used to achieve multiplexed, multifunctional and high capacity drug delivery as 
well as imaging,[21] this work opens up many new possibilities of rationally engineering drug 
delivery vehicles with advanced functions. 
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